A randomized control trial to assess optical coherence tomography parameters of the Xlimus drug-eluting stent: the XLIMIT trial

BACKGROUND: Third generation drug-eluting stents (DES) potentially offer better technical performance and reduced neointimal proliferation than previous generation DES. The XLIMIT non-inferiority trial evaluated the performance of the Xlimus (a novel sirolimus-eluting coronary stent system) in terms...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, Luca, Squillace, Mattia, Ventrella, Nicoletta, Moreno, Raul, Jiménez-Valero, Santiago, Serra, Antoni, Gomez Hospital, Joan Antoni, Bellamoli, Michele, Popolo Rubbio, Antonio, Bedogni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511894/
https://www.ncbi.nlm.nih.gov/pubmed/37745092
http://dx.doi.org/10.3389/fcvm.2023.1199475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511894/
https://www.ncbi.nlm.nih.gov/pubmed/37745092
http://dx.doi.org/10.3389/fcvm.2023.1199475

Ejemplares similares